# MSA Safety Inc: Form 10-Q for the period ended Mar 31, 2017

- Company: [MSA Safety Inc](/companies/msa.md) (CIK 66570)
- Form: 10-Q
- Filed: 2017-04-28
- Accepted by EDGAR: Apr 28, 2017, 09:19 ET
- Period: 2017-03-31
- Accession: 0000066570-17-000025
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/66570/000006657017000025/a10q-q12017.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/66570/000006657017000025/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2017-01-01 to 2017-03-31 | $146.0m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2017-01-01 to 2017-03-31 | $119.7m | us-gaap:GrossProfit |
| Research and development | 3 months, 2017-01-01 to 2017-03-31 | $11.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2017-01-01 to 2017-03-31 | $76.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-01-01 to 2017-03-31 | $19.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2017-01-01 to 2017-03-31 | $3.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-01-01 to 2017-03-31 | $1.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-01-01 to 2017-03-31 | $14.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-01-01 to 2017-03-31 | $0.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-01-01 to 2017-03-31 | $0.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-01-01 to 2017-03-31 | 38,593,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2017-01-01 to 2017-03-31 | $96.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2017-01-01 to 2017-03-31 | $1.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2017-01-01 to 2017-03-31 | $12.5m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2017-03-31 | $104.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-03-31 | $494.8m | us-gaap:AssetsCurrent |
| Total assets | at 2017-03-31 | $1.26bn | us-gaap:Assets |
| Current liabilities | at 2017-03-31 | $202.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-03-31 | $679.9m | us-gaap:Liabilities |
| Long-term debt | at 2017-03-31 | $268.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2017-03-31 | $26.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2017-03-31 | $576.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 25,987 characters.

*The following discussion and analysis should be read in conjunction with the historical financial statements and other financial information included elsewhere in this report on Form 10-Q. This discussion may contain forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business, and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in the sections of our annual report entitled “Forward-Looking Statements” and “Risk Factors.”*

### BUSINESS OVERVIEW

We are a global leader in the development, manufacture and supply of products that protect people and facility infrastructures. Our safety products typically integrate any combination of electronics, mechanical systems and advanced materials to protect users against hazardous or life threatening situations. Our comprehensive lines of safety products are used by workers around the world in a broad range of markets including the oil, gas, and petrochemical, fire service, construction, utilities, and mining industries, as well as the military. We are committed to providing our customers with service unmatched in the safety industry and, in the process, enhancing our ability to provide a growing line of safety solutions for customers in key global markets.

We tailor our product offerings and distribution strategy to satisfy distinct customer preferences that vary across geographic regions. To best serve these customer preferences, we have organized our business into six geographical operating segments that are aggregated into three reportable geographic segments: Americas, International and Corporate. In 2016, 59% and 41% of our net sales were made by our Americas and International segments, respectively.

*Americas*. Our largest manufacturing and research and development facilities are located in the United States. We serve our markets across the Americas with sales and distribution functions in the U.S., Mexico, Brazil, and Canada.

*International*. Our International segment includes companies in Europe, Middle East, Africa, and the Asia Pacific region, some of which are in developing regions of the world. In our largest International affiliates (in Germany, France, United Kingdom, Ireland and China), we develop, manufacture and sell a wide variety of products. In China, the products manufactured are sold primarily in the home country as well as regional markets. Operations in other International segment countries focus primarily on sales and distribution in their respective home country markets. Although some of these companies may perform limited production, most of their sales are of products manufactured in our plants in Germany, France, the U.S., United Kingdom, Ireland, Sweden and China or are purchased from third party vendors.

*Corporate*. The Corporate segment primarily consists of general and administrative expenses incurred in our corporate headquarters, costs associated with corporate development initiatives, legal expense, interest expense, foreign exchange gains or losses, and other centrally-managed costs. Corporate general and administrative costs comprise the majority of the expense in the Corporate segment.

### PRINCIPAL PRODUCTS

The following is a brief description of each of our principal product categories:

MSA's corporate strategy includes a focus on driving sales of core products, which have leading market positions and a competitive advantage. Core products include fixed gas and flame detection systems, breathing apparatus where SCBA is the principal product, portable gas detection instruments, industrial head protection products, fire and rescue helmets and fall protection devices. These products receive the highest levels of investment and resources as they typically realize a higher gross profit margin and provide higher levels of return on investment than non-core products. Core products comprised approximately 84% and 83% of sales for the three months ended March 31, 2017 and 2016, respectively.

MSA maintains a portfolio of non-core products, which include both adjacent and peripheral offerings. Adjacent products reinforce and extend the core, drawing upon our customer relationships, distribution channels, geographical presence and technical experience. These products are complementary to the core offerings and have their roots within the core product value chain. Key adjacent products include respirators, eye and face protection, thermal imaging cameras, and gas masks. Gas masks and ballistic helmet sales are the primary purchases from our military customers and were approximately $10.4 million and $13.5 million globally during the three months ended March 31, 2017 and 2016, respectively. Peripheral products are primarily sold to the mining industry and reflect a small portion of consolidated sales.

A detailed listing of our significant product offerings in the aforementioned product groups above is included in the MSA's Annual Report on Form 10-K for the year ended December 31, 2016.

### RESULTS OF OPERATIONS

### Three Months Ended March 31, 2017 Compared to Three Months Ended March 31, 2016

***Net Sales from continuing operations.*** Net sales for the three months ended March 31, 2017 were $265.8 million, a decrease of $13.5 million, or 5%, compared to $279.3 million for the three months ended March 31, 2016. Please refer to the Net Sales from Continuing Operations table for a reconciliation of the quarter over quarter sales change.

*(In millions)*

| Net Sales | Three Months Ended March 31, 2017 | 2016 | Dollar Increase (Decrease) | Percent Increase (Decrease) |
| --- | ---: | ---: | ---: | ---: |
| **Consolidated Continuing Operations** | **$265.8** | **$279.3** | **$(13.5)** | **(5)%** |
| Americas | 166.6 | 167.4 | (0.8) | —% |
| International | 99.2 | 111.9 | (12.7) | (11)% |

| Net Sales from Continuing Operations (Percent Change) | Three Months Ended March 31, 2017 versus March 31, 2016 Americas | International | Consolidated Continuing Operations |
| --- | ---: | ---: | ---: |
| **GAAP reported sales change** | **(0.5)%** | **(11.4)%** | **(4.8)%** |
| Currency translation effects | (0.4)% | 2.5% | 0.7% |
| Constant currency sales change | (0.9)% | (8.9)% | (4.1)% |

Note: Constant currency sales change is a non-GAAP financial measure provided by the Company to give a better understanding of the Company's underlying business performance. Constant currency sales change is calculated by removing the percentage impact of currency translation effects from the overall percentage change in net sales.

Net sales for the Americas segment were $166.6 million in the first quarter of 2017, a decrease of $0.8 million, compared to $167.4 million in the first quarter of 2016. During the quarter, constant currency sales in the Americas segment decreased 0.9% compared to the prior year period on a lower level of shipments of self-contained breathing apparatus ("SCBA") as the first quarter of 2016 benefited from a remaining backlog from 2015. This decrease was mostly offset by growth in industrial head protection and portable gas instruments on improving conditions in industrial markets.

Net sales for the International segment were $99.2 million in the first quarter of 2017, a decrease of $12.7 million, or 11%, compared to $111.9 million for the first quarter of 2016. Constant currency sales in the International segment decreased 8.9% during the first quarter, primarily due to a lower volume of military helmet and fall protection sales in Europe and less breathing apparatus sales across the segment, particularly in Asia.

***Gross profit.*** Gross profit for the first quarter of 2017 was $119.7 million, an decrease of $1.0 million, or 1%, compared to $120.7 million for the first quarter of 2016. The ratio of gross profit to net sales was 45.0% in the first quarter of 2017 compared to 43.2% in the same quarter last year. The higher gross profit ratio during the current quarter is attributable to improved margins across substantially all of our core products, particularly the G1 SCBA, associated with our value engineering initiatives and to a lesser degree, a more favorable product mix due to an increase in portable instruments and industrial head protection sales.

***Selling, general and administrative expenses.*** Selling, general and administrative expenses were $76.0 million during the first quarter of 2017, a decrease of $3.2 million or 4%, compared to $79.2 million in the first quarter of 2016 as we continue to realize benefits from our global cost reduction program. Selling, general and administrative expenses were 28.6% of net sales in the first quarter of 2017, compared to 28.4% of net sales in the first quarter of 2016.

***Research and development expense.*** Research and development expense was $11.0 million during the first quarter of 2017, an increase of $0.6 million, or 6%, compared to $10.4 million during the first quarter of 2016. Research and development expense was 4.1% of net sales in the first quarter of 2017, compared to 3.7% of net sales in the first quarter of 2016. We expect research and development expense to range from 4.0% to 4.5% of sales for the full year ending December 31, 2017 as we continue to develop new products for global safety markets, such as our new integrated thermal imaging camera ("iTIC") which was launched in late February 2017.

***Restructuring, net of adjustments.*** During the first quarter of 2017, the Company recorded restructuring charges of $12.7 million, primarily related to the voluntary retirement incentive package described below.

In September 2016, certain employees in the Americas segment were offered a voluntary retirement incentive package (“VRIP”). The election window for participation closed on October 17, 2016. The employees were required to render service through January 31, 2017 to receive the VRIP and had until February 6, 2017 to revoke their election. None of the 83 employees who accepted the VRIP revoked their election to retire under the terms of the plan. Non-cash special termination benefit expense of $11.4 million was incurred in the first quarter of 2017 related to these elections. All benefits were paid from our over funded North America pension plan.

During the first quarter of 2016, the Company recorded restructuring, net of adjustments, of $0.5 million, primarily related to severance costs for staff reductions associated with ongoing initiatives to right size our operations in Europe and Latin America.

***Currency exchange.*** Currency exchange losses were $0.6 million in the first quarter of 2017, compared to $2.0 million in the first quarter of 2016. Currency exchange losses in the first quarter of 2017 were related to management of foreign currency exposure on unsettled inter-company balances. Refer to Note 16 to the unaudited Condensed Consolidated Financial Statements in Part I Item I of this Form 10-Q, for information regarding our currency exchange rate risk management strategy.

***GAAP operating income.*** Consolidated operating income for the first quarter of 2017 was $19.4 million, a decrease of $9.3 million, or 32%, compared to $28.7 million in the same period last year. The reduction in operating income was primarily driven by restructuring charges associated with the voluntary retirement incentive package and was partially offset by improvements in gross margins discussed above and lower selling, general, and administrative expenses resulting from our cost reduction programs.

***Adjusted operating income.*** Americas adjusted operating income for the first quarter of 2017 was $38.1 million, an increase of $6.8 million, or 22%, compared to $31.3 million in the first quarter of 2016. We continued to see strength in gross margins during the first quarter from improvements in margins across substantially all of our core products, particularly the G1 SCBA, associated with our value engineering efforts and to a lesser degree, a favorable product mix related to higher sales of portable instruments and industrial head protection. Lower selling, general, and administrative costs also contributed to operating income results through effective cost management.

International adjusted operating income for the first quarter of 2017 was $6.6 million, a decrease of $1.8 million, or 21%, compared to $8.4 million in the prior year quarter. The decrease in adjusted operating income is primarily attributable to lower sales volumes.

Corporate segment adjusted operating loss for the first quarter of 2017 was $12.0 million, an increase of $3.4 million, or 40%, compared to an adjusted operating loss of $8.6 million in the first quarter of 2016, reflecting higher insurance, stock compensation and legal expense.

The following table represents a reconciliation from GAAP operating income to adjusted operating income. Adjusted operating margin % is calculated as adjusted operating income divided by net sales.

*(In millions)*

| Adjusted operating income | Three Months Ended March 31, 2017 Americas | International | Corporate | Consolidated Continuing Operations |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $166,568 | $99,197 | $— | $265,765 |
| GAAP operating income |  |  |  | 19,422 |
| Restructuring and other charges |  |  |  | 12,739 |
| Currency exchange losses, net |  |  |  | 580 |
| Adjusted operating income | 38,106 | 6,644 | (12,009) | 32,741 |
| Adjusted operating margin % | 22.9% | 6.7% |  |  |

Note: Adjusted operating income is a non-GAAP financial measure used by the chief operating decision maker to evaluate segment performance and allocate resources. Adjusted operating income is reconciled above to the nearest GAAP financial measure, Operating income.

***Total other expense, net.*** Other expense for the first quarter of 2017 was $2.9 million, compared to $3.0 million for the same period in 2016.

***Income taxes.*** The reported effective tax rate for the first quarter of 2017 was 10.9%, which included 16.9% of a tax benefit for certain share-based payments related to the adoption of ASU 2016-09 as discussed below. The reported effective tax rate for the first quarter of 2016 was 48.7%, which included 14% of a tax provision associated with exit taxes related to our European reorganization. The remaining effective tax rate decrease was primarily due to increased profitability in more favorable tax jurisdictions.

MSA finalized its European reorganization during 2016. The reorganization was designed to drive optimal performance by aligning certain strategic planning and decision making into a single location enabled by a common IT platform. During the first quarter of 2017, the Company incurred no charges associated with exit taxes related to our European reorganization, compared to $3.6 million for the first quarter of 2016.

In October 2016, the FASB issued ASU 2016-16, *Intra-entity Transfers of Assets Other than Inventory*. This ASU states that an entity should recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. We have early adopted this ASU on January 1, 2017 using the modified retrospective approach which resulted in a $5.9 million cumulative-effect adjustment directly to retained earnings for any previously deferred income tax effects.

In March 2016, the FASB issued ASU 2016-09, *Improvements to Employee Share-Based Payment Accounting*, which we have adopted effective January 1, 2017. From an income tax perspective, this ASU requires that all excess tax benefits and deficiencies that pertain to share-based payment arrangements be recognized as a component of income tax expense rather than as a component of additional paid-in-capital. We expect this to create volatility in the effective tax rate on a go-forward basis as the impact is treated as a discrete item within our quarterly tax provision. The adoption of this standard resulted in a $2.8 million tax benefit during the first quarter of 2017.

Please refer to Note 2 to the unaudited Condensed Consolidated Financial Statements in Part I Item 1 of this Form 10-Q for additional information regarding the two standards adopted.

***Net income from continuing operations attributable to MSA Safety Incorporated.*** Net income from continuing operations was $14.4 million for the first quarter of 2017, or $0.37 per diluted share, an increase of $1.7 million, or 13%, compared to $12.7 million, or $0.34 per diluted share, for the same period last year.

***Net (loss) income from discontinued operations attributable to MSA Safety Incorporated.*** Net loss from discontinued operations was $0.9 million for the first quarter of 2016, or $0.03 per diluted share. There was no discontinued operations activity for the first quarter of 2017. Please refer to Note 19 to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q.

### Non-GAAP Financial Information

We may provide information regarding adjusted operating income, which is not a recognized term under U.S. GAAP and does not purport to be alternatives to operating income or net income as a measure of operating performance. We believe that the use of this non-GAAP financial measure provides investors with additional useful information and provide a more complete understanding of the underlying results. Because not all companies use identical calculations, this presentation may not be comparable to similarly titled measures from other companies. For more information about this non-GAAP measure and a reconciliation to the nearest GAAP measure, please refer to the reconciliations referenced above in Management's Discussion & Analysis section and in Note 8 to the unaudited condensed consolidated financial statements of this Form 10-Q.

We may also provide financial information on a constant currency basis, which is a non-GAAP financial measure. These references to a constant currency basis do not include operational impacts that could result from fluctuations in foreign currency rates, which are outside of management's control. To provide information on a constant currency basis, the applicable financial results are adjusted by translating current and prior period results in local currency to a fixed foreign exchange rate. This approach is used for countries where the functional currency is the local country currency. This information is provided so that certain financial results can be viewed without the impact of fluctuations in foreign currency rates, thereby facilitating period-to-period comparisons of business performance. Constant currency information is not recognized under U.S. GAAP, and it is not intended as an alternative to U.S. GAAP measures.

### LIQUIDITY AND CAPITAL RESOURCES

Our main source of liquidity is operating cash flows, supplemented by borrowings. Our principal liquidity requirements are for working capital, capital expenditures, principal and interest payments on debt, acquisitions and dividend payments. Approximately 68% of our long-term debt is at fixed interest rates with repayment schedules through 2031. The remainder of our long-term debt is at variable rates, primarily on our unsecured revolving credit facility that is due in 2020. At March 31, 2017, approximately 74% of our borrowings are denominated in US dollars, which limits our exposure to currency exchange rate fluctuations.

At March 31, 2017, we had cash and cash equivalents totaling $104.4 million, of which $101.4 million was held by our foreign subsidiaries. Cash and cash equivalents are held by our foreign subsidiaries whose earnings are considered indefinitely reinvested at March 31, 2017. These funds could be subject to additional income taxes if repatriated. It is not practicable to determine the potential income tax liability that we would incur if these funds were repatriated to the U.S. because the time and manner of repatriation is uncertain. We believe that domestic cash and cash equivalents, domestic cash flows from operations, annual repatriation of a portion of the current period’s foreign earnings, and availability of our domestic line of credit continue to be sufficient to fund our domestic liquidity requirements.

Cash and cash equivalents decreased $9.3 million during the three months ended March 31, 2017, compared to increasing $6.0 million during the same period in 2016. The decrease in cash primarily relates to net payments on long-term debt of approximately $96.6 million partially offset by an increase in insurance receivable collections net of product liability settlements of $85.0 million and improved working capital management.

The Company currently has access to approximately $573.6 million of capital at March 31, 2017. Refer to Note 12 to the Condensed Consolidated Financial Statements in Part I Item 1 of this Form 10-Q.

***Operating activities.*** Operating activities provided cash of $96.4 million during the first quarter of 2017, compared to using $11.0 million during the same period in 2016. The increase in operating cash flows during the period was attributable to higher insurance receivable collections, improved working capital management and higher net income, driven by improved gross profit, SG&A cost management and lower taxes. We collected $85.0 million from insurance companies, net of product liability settlements paid, in the first quarter of 2017 while we paid settlements, net of collections from insurance companies, of $19.7 million in the first quarter of 2016.

***Investing activities.*** Investing activities used cash of $1.3 million during the three months ended March 31, 2017, compared to providing $9.9 million in the same period last year. The sale of our South African personal protective equipment distribution business and its Zambian operations drove cash inflows from investing activities in the first quarter of 2016. Refer to Note 19 to the Condensed Consolidated Financial Statements in Part I Item 1 of this Form 10-Q.

***Financing activities.*** Financing activities used cash of $106.0 million during the three months ended March 31, 2017, compared to providing $3.3 million during the same period in 2016. During the three months ended March 31, 2017, we used our insurance receivables proceeds to make net payments on long-term debt of approximately $96.6 million. This compared to net borrowings of $13.5 million during the same period in 2016. We paid cash dividends of $12.5 million during the three months ended March 31, 2017 compared to $11.9 million in the same period last year.

### CUMULATIVE TRANSLATION ADJUSTMENTS

The position of the U.S. dollar relative to international currencies at March 31, 2017 resulted in a translation gain of $11.4 million being recorded to the cumulative translation adjustments shareholders' equity account during the three months ended March 31, 2017, compared to a gain of $13.6 million during the same period in 2016. The translation gain during the first quarter of 2017 was primarily related to the strengthening of the euro, British pound, and Mexican peso relative to the U.S. dollar. The translation gain during the first three months of 2016 was primarily related to the strengthening of the euro and Brazilian real against the U.S. dollar.

### COMMITMENTS AND CONTINGENCIES

We made contributions of $1.5 million to our pension plans during the three months ended March 31, 2017. We expect to make total contributions of approximately $5.9 million to our pension plans in 2017 which are primarily associated with our International segment.

The Company had outstanding bank guarantees and standby letters of credit with banks as of March 31, 2017 totaling $12.3 million, of which $6.9 million related to the senior revolving credit facility. These letters of credit serve to cover customer requirements in connection with certain sales orders and insurance companies. No amounts were drawn on these arrangements at March 31, 2017. The Company is also required to provide cash collateral in connection with certain arrangements. At March 31, 2017, the Company has $0.8 million of restricted cash in support of these arrangements.

We have purchase commitments for materials, supplies, services, and property, plant and equipment as part of our ordinary conduct of business.

Please refer to Note 18 to the Condensed Consolidated Financial Statements in Part I Item 1 of this Form 10-Q for further discussion on the Company's product liabilities.

### CRITICAL ACCOUNTING POLICIES AND ESTIMATES

We prepare our consolidated financial statements in accordance with U.S. generally accepted accounting principles (GAAP). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures. We evaluate these estimates and judgments on an on-going basis based on historical experience and various assumptions that we believe to be reasonable under the circumstances. However, different amounts could be reported if we had used different assumptions and in light of different facts and circumstances. Actual amounts could differ from the estimates and judgments reflected in our consolidated financial statements.

The more critical judgments and estimates used in the preparation of our consolidated financial statements are discussed in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2016.

### RECENTLY ADOPTED AND RECENTLY ISSUED ACCOUNTING STANDARDS

Please refer to Note 2 to the Condensed Consolidated Financial Statements in Part I Item 1 of this Form 10-Q.

## Market risk

As filed, 2,428 characters.

Market risk represents the risk of adverse changes in the value of a financial instrument caused by changes in currency exchange rates, interest rates, and equity prices. We are exposed to market risks related to currency exchange rates and interest rates.

***Currency exchange rate sensitivity.*** We are subject to the effects of fluctuations in currency exchange rates on various transactions and on the translation of the reported financial position and operating results of our non-U.S. companies from local currencies to U.S. dollars. A hypothetical 10% strengthening or weakening of the U.S. dollar would decrease or increase our reported sales and net income by approximately $12.0 million and $1.6 million, respectively, for the three months ended March 31, 2017.

When appropriate, we may attempt to limit our transactional exposure to changes in currency exchange rates through contracts or other actions intended to reduce existing exposures by creating offsetting currency exposures. At March 31, 2017, we had open foreign currency forward contracts with a U.S. dollar notional value of $83.8 million. A hypothetical 10% increase in March 31, 2017 forward exchange rates would result in a $8.4 million increase in the fair value of these contracts.

***Interest rates.*** We are exposed to changes in interest rates primarily as a result of borrowing and investing activities used to maintain liquidity and fund business operations. Because of the relatively short maturities of temporary investments, these financial instruments are reported at carrying values that approximate fair values.

At March 31, 2017, we had $202.3 million of fixed rate debt which matures at various dates through 2031. The incremental increase in the fair value of fixed rate long-term debt resulting from a hypothetical 10% decrease in interest rates would be approximately $14.2 million. However, our sensitivity to interest rate declines and the corresponding increase in the fair value of our debt portfolio would unfavorably affect earnings and cash flows only to the extent that we elected to repurchase or retire all or a portion of our fixed rate debt portfolio at prices above carrying values.

At March 31, 2017, we had $94.5 million of variable rate borrowings under our revolving credit facility. A 100 basis point increase or decrease in interest rates could impact our future earnings under our current capital structure.

## Controls and procedures

As filed, 1,167 characters.

(a) *Evaluation of disclosure controls and procedures.* Based on their evaluation as of the end of the period covered by this Form 10-Q, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and (ii) accumulated and communicated to our management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding disclosure.

(b) *Changes in internal control*. There were no changes in the Company’s internal control over financial reporting that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

## Risk factors

As filed, 6,657 characters.

**We may experience losses from cumulative trauma product liability claims. The inability to collect insurance receivables and the transition to becoming largely self-insured for cumulative trauma product liability claims, could have a materially adverse effect on our business, operating results, financial condition and liquidity.**

Our subsidiary, Mine Safety Appliances Company, LLC (“MSA LLC”) is presently named as a defendant in 1,572 cumulative trauma lawsuits comprised of 2,797 claims. Cumulative trauma product liability claims involve exposures to harmful substances (e.g., silica, asbestos and coal dust) that occurred many years ago and may have developed over long periods of time into diseases such as silicosis, asbestosis, mesothelioma, or coal worker’s pneumoconiosis. The products at issue were manufactured many years ago and are not currently offered by MSA LLC. Although we have reserved against the portion of claims outstanding, the reserve does not take into account all the currently pending coal dust claims against MSA LLC or any incurred but not reported (“IBNR”) claims, which losses could have a materially adverse effect on our business, operating results, financial condition and liquidity. Because litigation is subject to inherent uncertainties, and unfavorable rulings or developments could occur, there can be no certainty that MSA LLC may not ultimately incur charges in excess of presently recorded liabilities with respect to claims included within the existing reserve or related to claims not included in the reserve. We will adjust the reserve for our liability relating to cumulative trauma claims from time to time based on the maturation of claims, developing facts and circumstances, and if actual experience is worse than previously projected. These adjustments may reflect changes in estimates for claims currently covered by the reserve, as well as estimated liabilities for claims not presently covered by the reserve and IBNR claims, in the event we become able to reasonably assess the probability and estimate the magnitude of potential losses. These adjustments may be material and could increase the year over year variability of our financial results.

In the normal course of business, MSA LLC, makes payments to settle these types of cumulative trauma product liability claims and for related defense costs, and records receivables for the amounts believed to be recoverable under insurance. MSA LLC has recorded insurance receivables totaling $58.5 million at March 31, 2017. As described in greater detail in Note 18 of the Condensed Consolidated Financial Statements, MSA LLC is currently involved in insurance coverage litigation regarding the rights and obligations under numerous insurance policies, and for the payment of amounts recorded as insurance receivables. Various factors could affect the timing and amount of recovery of insurance receivables, including: the outcome of coverage litigation, the outcome of negotiations with insurers, and the extent to which insurers may become insolvent in the future. Failure to recover amounts due from MSA LLC’s insurance carriers would result in it being unable to recover amounts already paid to resolve claims (and recorded as insurance receivables) and could have a materially adverse effect on our business, consolidated operating results, financial condition and liquidity.

Even if insurance coverage litigation is generally successful, we have determined that at some point in the next 18 months, MSA LLC will become largely self-insured for costs associated with cumulative trauma product liability claims and most of the related costs will be expensed without the expectation such costs will be covered by insurance reimbursement. The exact point when this transition will happen is difficult to predict and subject to a number of variables, including the pace at which future cumulative trauma product liability costs are incurred and the results of litigation and negotiations with insurance carriers. After it becomes largely self-insured, MSA LLC expects to still obtain some limited insurance reimbursement from negotiated coverage-in-place agreements (although that coverage may not be immediately triggered or accessible) or from other sources of coverage. However, the precise amount of insurance reimbursement that may be available cannot be determined with specificity at this time.

MSA LLC may experience an increase in newly filed claims or more aggressive settlement demands from plaintiffs at any time, which could accelerate the point at which MSA LLC becomes self-insured. We expect that once we become largely self-insured for cumulative trauma claims, we could experience greater year over year variability in our consolidated financial results.

On February 26, 2016, a Kentucky state court jury in the James Couch claim rendered a verdict against MSA LLC (the "Couch verdict") of $7.2 million dollars (comprised of $3.2 million of an apportioned share of compensatory damages and $4.0 million in punitive damages). The Couch claim is a cumulative trauma product liability lawsuit involving exposure to coal dust. MSA LLC is appealing the Couch verdict. MSA LLC experienced an increase in coal dust related claims filed in 2016. Such claims could result in increased product liability expense in the future, and the impact of such an increase in claims to our results of operations may be worsened to the extent MSA LLC is self-insured. Please refer to Note 18 of the Condensed Consolidated Financial Statements for further details on the Couch verdict.

**Claims of injuries from our products, product defects or recalls of our products could have a materially adverse effect on our business, operating results, financial condition and liquidity.**

MSA and its subsidiaries face an inherent business risk of exposure to product liability claims arising from the alleged failure of our products to prevent the types of personal injury or death against which they are designed to protect. In the event the parties using our products are injured or any of our products prove to be defective, we could be subject to claims with respect to such injuries. In addition, we may be required to or may voluntarily recall or redesign certain products that could potentially be harmful to end users. Any claim or product recall that results in significant expense or adverse publicity against us could have a materially adverse effect on our business, consolidated operating results, financial condition and liquidity, including any successful claim brought against us in excess or outside of available insurance coverage.

Filed Apr 28, 2017.
Source: SEC EDGAR, the filing index for accession 0000066570-17-000025. Last ingested by Listed: Nov 3, 2026, 21:35 ET. No prices; not investment advice.
